Company page

Insmed Incorporated

Insmed Incorporated, trading under the ticker INSM, is a public company based in America with a market capitalization of approximately $20.8 billion. The company focuses on developing innovative therapies for patients with rare diseases. Insmed is committed to advancing its pipeline of treatments and improving patient outcomes.